ArticleIntestinal research2021

Long-term safety and effectiveness of adalimumab in Japanese patients with Crohn's disease: 3-year results from a real-world study.

Tadakazu Hisamatsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.